Right and Left Ventricular Myocardial Perfusion Reserves Correlate with Right Ventricular Function and Pulmonary Hemodynamics in Patients with Pulmonary Arterial Hypertension
- 1 January 2011
- journal article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 258 (1), 119-127
- https://doi.org/10.1148/radiol.10100725
Abstract
Purpose To evaluate the relationships of right ventricular (RV) and left ventricular (LV) myocardial perfusion reserves with ventricular function and pulmonary hemodynamics in patients with pulmonary arterial hypertension (PAH) by using adenosine stress perfusion cardiac magnetic resonance (MR) imaging. Materials and Methods This HIPAA-compliant study was institutional review board approved. Twenty-five patients known or suspected to have PAH underwent right heart catheterization and adenosine stress MR imaging on the same day. Sixteen matched healthy control subjects underwent cardiac MR imaging only. RV and LV perfusion values at rest and at adenosine-induced stress were calculated by using the Fermi function model. The MR imaging–derived RV and LV functional data were calculated by using dedicated software. Statistical testing included Kruskal-Wallis tests for continuous data, Spearman rank correlation tests, and multiple linear regression analyses. Results Seventeen of the 25 patients had PAH: 11 with scleroderma-associated PAH, and six with idiopathic PAH. The remaining eight patients had scleroderma without PAH. The myocardial perfusion reserve indexes (MPRIs) in the PAH group (median RV MPRI, 1.7 [25th–75th percentile range, 1.3–2.0]; median LV MPRI, 1.8 [25th–75th percentile range, 1.6–2.1]) were significantly lower than those in the scleroderma non-PAH (median RV MPRI, 2.5 [25th–75th percentile range, 1.8–3.9] [P = .03]; median LV MPRI, 4.1 [25th–75th percentile range, 2.6–4.8] [P = .0003]) and control (median RV MPRI, 2.9 [25th–75th percentile range, 2.6–3.6] [P < .01]; median LV MPRI, 3.6 [25th–75th percentile range, 2.7–4.1] [P < .01]) groups. There were significant correlations between biventricular MPRI and both mean pulmonary arterial pressure (mPAP) (RV MPRI: ρ = −0.59, Bonferroni P = .036; LV MPRI: ρ = −0.79, Bonferroni P < .002) and RV stroke work index (RV MPRI: ρ = −0.63, Bonferroni P = .01; LV MPRI: ρ = −0.75, Bonferroni P < .002). In linear regression analysis, mPAP and RV ejection fraction were independent predictors of RV MPRI. mPAP was an independent predictor of LV MPRI. Conclusion Biventricular vasoreactivity is significantly reduced with PAH and inversely correlated with RV workload and ejection fraction, suggesting that reduced myocardial perfusion reserve may contribute to RV dysfunction in patients with PAH. © RSNA, 2010Keywords
This publication has 38 references indexed in Scilit:
- Peripheral Arterial Stiffness and Endothelial Dysfunction in Idiopathic and Scleroderma Associated Pulmonary Arterial HypertensionThe Journal of Rheumatology, 2009
- Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patientsAnnals Of The Rheumatic Diseases, 2008
- k-Space and Time Sensitivity Encoding–accelerated Myocardial Perfusion MR Imaging at 3.0 T: Comparison with 1.5 TRadiology, 2008
- High spatial resolution myocardial perfusion cardiac magnetic resonance for the detection of coronary artery diseaseEuropean Heart Journal, 2008
- Fast mapping of myocardial blood flow with MR first‐pass perfusion imagingMagnetic Resonance in Medicine, 2008
- Assessment of Myocardial Viability Using Delayed Enhancement Magnetic Resonance Imaging at 3.0 TeslaInvestigative Radiology, 2006
- Clinical classification of pulmonary hypertensionJournal of the American College of Cardiology, 2004
- Comparison of relation of systolic flow of the right coronary artery to pulmonary artery pressure in patients with and without pulmonary hypertensionThe American Journal of Cardiology, 1996
- A controlled, powerful multiple-comparison strategy for several situations.Psychological Bulletin, 1994
- Reduced coronary flow and resistance reserve in primary scleroderma myocardial diseaseAmerican Heart Journal, 1986